Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 479,000 $ 543,754,000 $ (410,188,000) $ 134,045,000
Beginning balance, shares at Dec. 31, 2018 47,944,486        
Stock option-based compensation expense 2,103,000 2,103,000
Restricted stock-based compensation expense 172,000 172,000
Common stock issued for cash exercise of options 28,000 28,000
Common stock issued for cash exercise of options, shares 5,208        
Net loss (18,555,000) (18,555,000)
Ending balance, value at Mar. 31, 2019 $ 479,000 546,057,000 (428,743,000) 117,793,000
Ending balance, shares at Mar. 31, 2019 47,949,694        
Beginning balance, value at Dec. 31, 2018 $ 479,000 543,754,000 (410,188,000) 134,045,000
Beginning balance, shares at Dec. 31, 2018 47,944,486        
Other comprehensive loss        
Net loss         (42,479,000)
Ending balance, value at Jun. 30, 2019 $ 492,000 559,335,000 (452,667,000) 107,160,000
Ending balance, shares at Jun. 30, 2019 49,249,497        
Beginning balance, value at Mar. 31, 2019 $ 479,000 546,057,000 (428,743,000) 117,793,000
Beginning balance, shares at Mar. 31, 2019 47,949,694        
Stock option-based compensation expense 1,678,000 1,678,000
Restricted stock-based compensation expense 78,000 78,000
Common stock issued for cash exercise of options $ 1,000 384,000 385,000
Common stock issued for cash exercise of options, shares 91,126        
Common stock issued for cash under open market sale agreement $ 17,000 12,605,000 12,622,000
Common stock issued for cash under open market sale agreement, shares 1,658,677        
Shares returned in connection with arbitration ruling on licensing agreement $ (5,000) (1,467,000) (1,472,000)
Shares returned in connection with arbitration ruling on licensing agreement, shares (450,000)        
Other comprehensive loss        
Net loss (23,924,000) (23,924,000)
Ending balance, value at Jun. 30, 2019 $ 492,000 559,335,000 (452,667,000) 107,160,000
Ending balance, shares at Jun. 30, 2019 49,249,497        
Beginning balance, value at Dec. 31, 2019 $ 836,000 664,064,000 (486,470,000) 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Stock option-based compensation expense 1,256,000 1,256,000
Restricted stock-based compensation expense 464,000 464,000
Other comprehensive loss 386,000 386,000
Net loss (48,159,000) (48,159,000)
Ending balance, value at Mar. 31, 2020 $ 836,000 665,784,000 (534,629,000) 386,000 132,377,000
Ending balance, shares at Mar. 31, 2020 83,622,135        
Beginning balance, value at Dec. 31, 2019 $ 836,000 664,064,000 (486,470,000) 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Other comprehensive loss         133,000
Net loss         (61,169,000)
Ending balance, value at Jun. 30, 2020 $ 848,000 667,712,000 (547,639,000) 133,000 121,054,000
Ending balance, shares at Jun. 30, 2020 84,781,241        
Beginning balance, value at Mar. 31, 2020 $ 836,000 665,784,000 (534,629,000) 386,000 132,377,000
Beginning balance, shares at Mar. 31, 2020 83,622,135        
Stock option-based compensation expense 1,578,000 1,578,000
Restricted stock-based compensation expense 187,000 187,000
Common stock issued for cash exercise of options $ 1,000 174,000 175,000
Common stock issued for cash exercise of options, shares 75,793        
Issuance of common stock in connection with restricted share awards $ 11,000 (11,000)
Issuance of common stock in connection with restricted share awards, shares 1,083,313        
Other comprehensive loss (253,000) (253,000)
Net loss (13,010,000) (13,010,000)
Ending balance, value at Jun. 30, 2020 $ 848,000 $ 667,712,000 $ (547,639,000) $ 133,000 $ 121,054,000
Ending balance, shares at Jun. 30, 2020 84,781,241